Metabolites
Displaying metabolites 1426 - 1450 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB24792 | DG(16:0/14:0(3-OH)/0:0) | (2S)-2-hydroxy-3-[(3-hydroxytetradecanoyl)oxy]propyl hexadecanoate | phospholipid biosynthesis (CL(16:0/14:0(3-OH)/16:0/14:0(3-OH))) PW001951 | 556.869 C33H64O6 | |
ECMDB01178 | Adenosine diphosphate ribose 20762-30-5 | [({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy})phosphinic acid | 559.3157 C15H23N5O14P2 | ||
ECMDB04137 | Phosphoribosyl-AMP | {[(2R,3S,4R,5R)-5-{1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-6-imino-6,9-dihydro-1H-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | 559.3157 C15H23N5O14P2 | ||
ECMDB21367 | Uridine 5''-diphospho-{beta}-4-deoxy-4-formamido-L-arabinose | N-[(3S,4S,5R,6R)-6-({[({[(2R,3S,4R)-3,4-dihydroxy-5-(4-oxido-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-4,5-dihydroxyoxan-3-yl]carboximidate | 561.2853 C15H21N3O16P2 | ||
ECMDB20298 | TDP-Glucose | {[hydroxy({[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 | 562.3131 C16H24N2O16P2 | |
ECMDB00241 | Protoporphyrin IX 553-12-8 | 3-[20-(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(21),2,4,6,8(23),9,11,13,15,17,19-undecaen-4-yl]propanoic acid | Porphyrin metabolism PW000936 | 562.6582 C34H34N4O4 | |
ECMDB23143 | 6-Methoxy-3-methyl-2-all-trans-hexaprenyl-1,4-benzoquinol | 3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-methoxy-2-methylbenzene-1,4-diol | 562.8653 C38H58O3 | ||
ECMDB04033 | CDPglucose | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-({[hydroxy({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphoryl phosphonato]oxy}methyl)oxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-olate | Starch and sucrose metabolism PW000941 | 563.3011 C15H23N3O16P2 | |
ECMDB23199 | UDP-4-Deoxy-4-formamido-beta-L-arabinose | N-[(3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-4,5-dihydroxyoxan-3-yl]carboximidic acid | 563.3011 C15H23N3O16P2 | ||
ECMDB24224 | UDP-α-D-galactose | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | 564.287 C15H22N2O17P2 | ||
ECMDB01328 | dTDP-D-Glucose 2196-62-5 | {[hydroxy({[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphoryl]oxy}({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | 564.329 C16H26N2O16P2 | ||
ECMDB06876 | dTDP-D-Galactose 5817-97-0 | {[hydroxy({[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphoryl]oxy}({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | 564.329 C16H26N2O16P2 | ||
ECMDB21185 | Aerobactin 26198-65-2 | (2S)-2-[3-carboxy-3-({[(1S)-1-carboxy-5-(N-hydroxyacetamido)pentyl]carbamoyl}methyl)-3-hydroxypropanamido]-6-(N-hydroxyacetamido)hexanoic acid | 564.5402 C22H36N4O13 | ||
ECMDB21104 | 1,2-Diacyl-sn-glycerol (dihexadec-9-enoyl, n-C16:1) | (2S)-1-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropan-2-yl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(16:1(9Z)/16:1(9Z)/18:1(9Z)/18:1(9Z)) PW001549 | 564.8797 C35H64O5 | |
ECMDB24788 | DG(15:0cyclo/17:0cycw7c/0:0) | (2S)-3-{[8-(2-butylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 8-(2-hexylcyclopropyl)octanoate | phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:0/16:0) PW001145 | 564.892 C35H64O5 | |
ECMDB24806 | DG(17:0cycw7c/15:0cyclo/0:0) | (2R)-3-{[8-(2-hexylcyclopropyl)octanoyl]oxy}-2-hydroxypropyl 8-(2-butylcyclopropyl)octanoate | phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/17:0cycw7c/15:0cyclo) PW001169 | 564.892 C35H64O5 | |
ECMDB23291 | DG(16:1(9Z)/16:1(9Z)/0:0) | 3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropyl (9Z)-hexadec-9-enoate | 564.892 C35H64O5 | ||
ECMDB00302 | Uridine diphosphategalactose 2956-16-3 | [({[(2S,3R,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | 566.3018 C15H24N2O17P2 | ||
ECMDB04165 | UDP-D-Galacto-1,4-furanose 638-23-3 | [({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4R,5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy})phosphinic acid | 566.3018 C15H24N2O17P2 | ||
ECMDB04171 | UDP-Glucose 133-89-1 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | Lipopolysaccharide biosynthesis PW000831 More...Amino sugar and nucleotide sugar metabolism II PW000887 Amino sugar and nucleotide sugar metabolism III PW000895 colanic acid building blocks biosynthesis PW000951 galactose degradation/Leloir Pathway PW000884 lipopolysaccharide biosynthesis II PW001905 lipopolysaccharide biosynthesis III PW002059 trehalose biosynthesis I PW002088 | 566.3018 C15H24N2O17P2 | |
ECMDB20088 | 4-Glutathionyl cyclophosphamide | 2-amino-4-{[2-({2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2λ⁵-oxazaphosphinan-4-yl}sulfanyl)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid | 566.394 C17H30Cl2N5O8PS | ||
ECMDB23266 | DG(14:0/18:1(9Z)/0:0) | (2S)-2-hydroxy-3-(tetradecanoyloxy)propyl (9Z)-octadec-9-enoate | 566.908 C35H66O5 | ||
ECMDB23282 | DG(16:0/16:1(9Z)/0:0) | (2S)-3-(hexadecanoyloxy)-2-hydroxypropyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(16:0/16:1(9Z)/16:0/16:1(9Z)) PW001297 | 566.908 C35H66O5 | |
ECMDB23290 | DG(16:1(9Z)/16:0/0:0) | (2R)-3-(hexadecanoyloxy)-2-hydroxypropyl (9Z)-hexadec-9-enoate | phospholipid biosynthesis CL(16:1(9Z)/16:0/16:1(9Z)/16:0) PW001486 | 566.908 C35H66O5 | |
ECMDB23306 | DG(18:1(9Z)/14:0/0:0) | (2R)-2-hydroxy-3-(tetradecanoyloxy)propyl (9Z)-octadec-9-enoate | phospholipid biosynthesis (CL(18:1(9Z)/14:0/19:0cycv8c/19:0cycv8c) 2) PW001781 | 566.908 C35H66O5 |